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ABSTRACT Toxoplasma gondii is a widespread protozoan parasite that causes po-
tentially life-threatening opportunistic disease. New inhibitors of parasite replication
are urgently needed, as the current antifolate treatment is also toxic to patients. Mi-
crotubules are essential cytoskeletal components that have been selectively targeted
in microbial pathogens; further study of tubulin in Toxoplasma may reveal novel
therapeutic opportunities. It has been noted that -tubulin acetylation at lysine 40
(K40) is enriched during daughter parasite formation, but the impact of this modiﬁ-
cation on Toxoplasma division and the enzyme mediating its delivery have not been
identiﬁed. We performed mutational analyses to provide evidence that K40 acetyla-
tion stabilizes Toxoplasma microtubules and is required for parasite replication. We
also show that an unusual Toxoplasma homologue of -tubulin acetyltransferase
(TgATAT) is expressed in a cell cycle-regulated manner and that its expression peaks
during division. Disruption of TgATAT with CRISPR/Cas9 ablates K40 acetylation and
induces replication defects; parasites appear to initiate mitosis yet exhibit incom-
plete or improper nuclear division. Together, these ﬁndings establish the importance
of tubulin acetylation, exposing a new vulnerability in Toxoplasma that could be
pharmacologically targeted.
IMPORTANCE Toxoplasma gondii is an opportunistic parasite that infects at least
one-third of the world population. New treatments for the disease (toxoplasmosis)
are needed since current drugs are toxic to patients. Microtubules are essential cel-
lular structures built from tubulin that show promise as antimicrobial drug targets.
Microtubules can be regulated by chemical modiﬁcation, such as acetylation on
lysine 40 (K40). To determine the role of K40 acetylation in Toxoplasma and whether
it is a liability to the parasite, we performed mutational analyses of the -tubulin
gene. Our results indicate that parasites cannot survive without K40 acetylation un-
less microtubules are stabilized with a secondary mutation. Additionally, we identi-
ﬁed the parasite enzyme that acetylates -tubulin (TgATAT). Genetic disruption of
TgATAT caused severe defects in parasite replication, further highlighting the impor-
tance of -tubulin K40 acetylation in Toxoplasma and its promise as a potential new
drug target.
KEYWORDS: microtubules, cytoskeleton, lysine acetylation, Mec-17, acetyltransferase,
endodyogeny
Toxoplasma gondii is an obligate intracellular protozoan parasite in the phylumApicomplexa, which also includes Plasmodium spp. and Cryptosporidium spp., the
causative agents of malaria and cryptosporidiosis, respectively. Toxoplasma is capable
of infecting virtually any nucleated cell in warm-blooded animals and is estimated to be
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present in ~30% of humans worldwide (1). Toxoplasma can infect a new host congen-
itally or following the ingestion of oocysts shed in the feces of cats (the deﬁnitive host)
or tissue cysts present in undercooked meat (2). While the immune system is capable
of controlling the acute infection caused by the rapidly proliferating tachyzoite stage of
the parasite, Toxoplasma is able to differentiate into a latent bradyzoite stage, estab-
lishing a chronic infection that remains for the life of the host. Reactivation of these
bradyzoite cysts in immunocompromised individuals can lead to debilitating or life-
threatening disease; for example, toxoplasmosis accounts for 10 to 30% of the deaths
of HIV/AIDS patients (3, 4) and is a risk factor for patients receiving organ transplants
or undergoing immunosuppressive chemotherapies (5–8). The frontline antifolate treat-
ment is effective at targeting the replicative stage, but serious toxicity issues necessi-
tate the identiﬁcation of better drug targets (9).
Constructed from tubulin monomers, microtubules are a component of the cyto-
skeleton and are required for a variety of steps in Toxoplasma biology, including
parasite replication (10). Upon invasion, tachyzoites undergo a form of asexual division
termed endodyogeny (11, 12) in which two daughter parasites assemble within the
mother parasite. This complex process is dependent upon the function of two distinct
microtubule populations (13, 14). The spindle microtubules originate from a
microtubule-organizing center (MTOC) termed the centrosome and ensure proper
chromosome segregation and karyokinesis as the parasite completes each round of
closed (intranuclear) mitosis (13, 14). Progression through mitosis is partnered with
expansion of the daughter parasite cytoskeleton driven by elongation of the 22
subpellicular microtubules from a second MTOC, the apical polar ring, toward the basal
end of the parasite. Once formed, the subpellicular microtubules are nondynamic,
tethered to the cytosolic face of the parasite inner membrane complex (IMC), a
collection of ﬂattened vesicles originating from the endoplasmic reticulum-Golgi net-
work (15). In addition to replication, microtubules play critical roles in a variety of
aspects of Toxoplasma biology, including parasite motility, host cell attachment, and
invasion; consequently, microtubules have emerged as attractive targets for therapeu-
tic intervention (10). In addition, the mechanisms by which Toxoplasma microtubules
are regulated is an active area of inquiry.
Microtubule functions are regulated by a diverse collection of posttranslational
modiﬁcations (PTMs) that occur on the - and -tubulin subunits that make up
microtubule polymers (16–19). Most of these tubulin PTMs occur on the C-terminal tails
that extend out from the surface of the microtubules to regulate interactions with
effector microtubule-associated proteins (20, 21). In contrast, acetylation of lysine 40
(K40) on -tubulin is a unique PTM that resides within the lumen of microtubules (22,
23). K40 acetylation is well conserved across eukaryotes, and the primary acetyltrans-
ferase that delivers this PTM was recently identiﬁed as Mec-17/ATAT, a Gcn5-related
N-acetyltransferase (24, 25). Originally identiﬁed in the ﬂagella of the unicellular green
alga Chlamydomonas reinhardtii (26, 27), K40 acetylation was subsequently found to be
enriched on long-lived microtubules throughout higher eukaryotes (28, 29). Recent
studies with Caenorhabditis elegans suggest that K40 acetylation stabilizes microtubules
by promoting the formation of a salt bridge that augments interactions between
-tubulin subunits in adjacent protoﬁlaments (30). Despite mounting evidence sup-
porting a role for K40 acetylation in microtubule stability, the biological function of this
PTM in vivo remains unclear, as evidenced by the variety of phenotypes observed across
numerous systems when K40 acetylation is manipulated (24, 31–33).
Numerous tubulin PTMs, including acetylation of K40, have been catalogued in
Toxoplasma (34–37), but the functional importance of these modiﬁcations for micro-
tubule dynamics and parasite biology remains largely undeﬁned. In this study, we
established the role of -tubulin K40 acetylation by generating endogenous -tubulin
point mutants and through CRISPR-mediated disruption of the Toxoplasma -tubulin
acetyltransferase orthologue (named TgATAT). Together, these approaches reveal that
K40 acetylation is critical for the stabilization of tachyzoite microtubules, which is
required for daughter cell formation and karyokinesis. The discovery that TgATAT-
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mediated acetylation of -tubulin is necessary for Toxoplasma replication establishes
the importance of tubulin PTMs in apicomplexan parasites.
RESULTS
K40 acetylation is dispensable only if tubulin is stabilized through another
mutation. Toxoplasma -tubulin can be acetylated at K40, but the functional signiﬁ-
cance of this PTM has yet to be addressed. Three -tubulin isotypes are present in the
Toxoplasma genome: TGME49_316400 (TgTUBA1), TGME49_231770 (putative -tubulin
I), and TGME49_231400 (tubulin/Ftsz family). TgTUBA1 is the only isotype expressed in
tachyzoites and the only one that contains the conserved K40 residue reported as
acetylated (34). To address the role of -tubulin K40 acetylation in tachyzoites, we
generated three parasite clones with different K40 mutations in the endogenous
TgTUBA1 genomic locus: (i) lysine to arginine (K40R), which conserves the positive
charge of lysine but prevents acetylation, (ii) lysine to glutamine (K40Q), which is an
acetyl-lysine mimic (38), and (iii) a silent mutation as a control (K40K). To select for
positive clones harboring mutant K40, our construct included a second mutation that
confers resistance to the microtubule-disrupting drug oryzalin (39, 40). Since studies
with other species suggest that K40 acetylation stabilizes microtubules, we chose to
generate oryzalin resistance by mutating valine 252 to lysine (V252L), a mutation in the
GTPase-activating domain that provides high levels of oryzalin resistance but has no
effect on microtubule stability (41).
Figure 1A illustrates the allelic replacement strategy used to make K40 mutants by
FIG 1 Ablation of K40 acetylation is not tolerated unless it is replaced with the K40Q acetyl-lysine mimic. (A) Diagram of TgTUBA1
genomic locus aligned with the construct used to replace the endogenous locus by double homologous recombination. The construct
contains the nonstabilizing V252L oryzalin resistance mutation and the K40K, K40R, or K40Q mutation. (B) IFAs of K40 mutants stained
for acetyl-K40–-tubulin (red) or -tubulin (specific to Toxoplasma, green). The K40Q mutation results in complete loss of K40
acetylation in the parasite but not its host cell. Images were merged with the DNA stain DAPI (blue). Scale bars, 3 m. (C) Western blot
(WB) assay of parental RH and mutant parasites showing loss of K40 acetylation in K40Q mutants. The blot was probed with
anti-acetyl-K40–-tubulin and anti-SAG1 antibodies as a loading control. (D) Doubling assays performed to assess the growth of parental
RH and mutant parasites. Replication rates were determined by counting the parasites within 100 random vacuoles at 24 h postinfection.
Three independent trials were conducted, and the average percentage of vacuoles with the indicated number of parasites  the
standard error of the mean is shown (no significant difference between mean percentages of vacuoles at each stage between strains as
determined by two-way analysis of variance).
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using the nonstabilizing V252L mutation to confer oryzalin resistance. The TgTUBA1
gene was ampliﬁed from genomic DNA isolated from oryzalin-resistant clones, and the
presence of the expected mutations in each established line was conﬁrmed by se-
quencing. While both the K40K and K40Q mutations were readily obtained, K40R
mutant parasites were never obtained despite seven independent attempts. The
acetylation status of -tubulin K40 was assessed by using both immunoﬂuorescence
assays (IFAs) and Western blotting (Fig. 1B and C). K40Q mutant parasites show a
complete loss of K40 acetylation (as expected, the glutamine acetyl-lysine mimic does
not cross-react with the anti-K40-acetyl -tubulin antibody) but no obvious defects in
any microtubule structures, as visualized with a Toxoplasma-speciﬁc -tubulin antibody
(Fig. 1B). It is noted that cross-reactivity of the K40-acetyl antibody used (6-11B-1)
results in a signal from the host microtubules outside the parasitophorous vacuole (PV)
(for example, Fig. 1B, K40K and K40Q). Host microtubules are actively recruited to the
PV shortly after invasion by Toxoplasma (42); variability in the enrichment of host
microtubules accounts for the variation in the K40-acetyl signal observed in host cells.
Parasite growth assays further show that replacement of K40 with the glutamine
acetyl-lysine mimic (K40Q) did not affect the replication rate (Fig. 1D).
Some mutations in the oryzalin binding pocket stabilize microtubules by promoting
protoﬁlament interactions and tubulin polymerization (41). Given the reported role of
K40 acetylation in microtubule stability, we hypothesized that an oryzalin-resistant
mutation in this binding pocket might allow the generation of K40R mutants. We
therefore generated constructs containing K40K, K40R, and K40Q by using the T239I
oryzalin binding pocket mutation (Fig. 2A), which was chosen for the similarity of its
levels of drug resistance to those of V252L (43). Sequencing of the TgTUBA1 gene
conﬁrmed the presence of both mutations in the oryzalin-resistant clones. In the T239I
FIG 2 K40 acetylation is dispensable in the presence of the T239I oryzalin resistance mutation. (A) Diagram of the TgTUBA1 genomic
locus aligned with the allelic replacement construct containing the oryzalin resistance mutation T239I and the K40K, K40R, or K40Q
mutation. (B) IFAs of mutant parasite lines stained for acetyl-K40–-tubulin (red) or -tubulin (green). Images were merged with the DNA
stain DAPI (blue). Scale bars, 3 m. (C) Western blot (WB) assay of parental RH and mutants confirms the loss of K40 acetylation in K40Q
and K40R parasites. The blots were probed with anti-acetyl-K40–-tubulin and anti-SAG1 antibodies as a loading control. (D) Doubling
assays performed as described in the legend to Fig. 1D to assess the growth of parental RH and mutant parasites.
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oryzalin-resistant background, all K40 mutants, including K40R, were readily obtained.
Both K40Q and K40R parasites showed a complete loss of K40 acetylation, as visualized
by both IFA and Western blotting (Fig. 2B and C), yet displayed no difference in
replication relative to the silent mutation or the wild type (Fig. 2D).
Our mutational analyses show that ablation of -tubulin K40 acetylation is possible
only when a second, stabilizing mutation (e.g., T239I) is present or when K40 is mutated
to a residue (glutamine) that mimics an acetylated lysine. These results suggest that K40
acetylation is required in tachyzoites and likely contributes to the stabilization of
microtubules.
Identiﬁcation of an acetyltransferase that colocalizes with acetylated tu-
bulin during tachyzoite division. To further characterize the role of -tubulin K40
acetylation in tachyzoites, we sought to identify the enzyme delivering this PTM. In
other species, -tubulin acetyltransferase (ATAT, also known as Mec-17) has been
implicated as the primary enzyme acetylating tubulin (24, 25, 44, 45). A bioinformatic
survey of ToxoDB.org v.24 (46) revealed a single gene containing a Mec-17 domain
belonging to the Gcn5-related superfamily, TGME49_319600, which we will refer to as
TgATAT. TgATAT is located on chromosome IV and contains two exons encoding a
predicted protein of 907 amino acids (Fig. 3A). We aligned the lysine acetyltransferase
(KAT) domains of ATAT homologues from several representative species with Clustal
Omega (47, 48) (Fig. 3B). Interestingly, while the Mec-17 domain is highly conserved,
including the key residues critical for enzymatic activity (Fig. 3B), the predicted TgATAT
protein is considerably larger than all previously characterized ATAT/Mec-17 proteins
(Fig. 3A) (24, 44). TgATAT transcripts are expressed in tachyzoites, peaking in the early
stages of mitosis, waning during cytokinesis, and remaining at basal levels during
interphase, suggesting that TgATAT is a cell cycle-regulated protein (46, 49).
To conﬁrm the unusual size and assess the expression patterns of TgATAT, we
introduced three C-terminal hemagglutinin (3HA) epitope tags at the endogenous
TgATAT locus by single-crossover homologous recombination in the RHΔku80Δhxgprt
parasites (50, 51). TgATATHA resolves as a single band migrating at the predicted size
FIG 3 Comparison of ATAT/Mec-17 homologues. (A) Depiction of ATAT protein sequences from T. gondii (TgATAT,
TGME49_31600), Plasmodium falciparum (PfATAT, PF3D7_0924900), Homo sapiens (HsMec17, XP_005249477.1), Tetrahymena
thermophila (TtMec17, TTHERM_00355780), and C. elegans (CeATAT2, CELE_W06B11.1), with the number of amino acids (aa) in
parentheses. Gray boxes represent the lysine acetyltransferase domain. (B) Amino acid sequence alignment of the KAT domain
of the indicated ATAT homologues with identical residues highlighted in black and similar residues highlighted in gray. The
asterisk denotes an aspartic acid residue previously shown to be important for ATAT activity (43).
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of 98 kDa, and the C-terminal 3HA tag had no effect on K40 acetylation (Fig. 4A). IFAs
show that TgATATHA exhibits cell cycle-regulated expression, with low levels appearing
during S phase and mitosis and peak levels occurring during early cytokinesis (Fig. 4B).
In agreement with the mRNA expression data (49), TgATATHA protein levels decrease as
tachyzoites complete division and then remain undetectable throughout interphase
(Fig. 4B). In agreement with other studies (35, 37), we observed that -tubulin K40
acetylation occurs at both spindle and subpellicular microtubules during early daughter
formation (Fig. 4C). Collectively, these ﬁndings suggest that TgATAT is expressed during
the early stages of tachyzoite replication, when acetylation of nascent microtubule
structures occurs.
Disruption of TgATAT leads to loss of -tubulin K40 acetylation. To deter-
mine the impact of TgATAT on -tubulin K40 acetylation, we attempted to knock out
the genomic locus by double homologous recombination but could not isolate viable
clones, which suggests that TgATAT may be essential in tachyzoites. We then employed
the CRISPR/Cas9 system recently reported for Toxoplasma (52, 53) by transfecting a
plasmid encoding a green ﬂuorescent protein (GFP)-Cas9 fusion and a TgATAT-
targeting single guide RNA (sgRNA) into our TgATATHA parasites. Along with the
FIG 4 Expression of TgATAT and acetylated -tubulin during the tachyzoite cell cycle. (A) Western blot (WB) assay of lysates from the
parental strain (RHhxku80) and parasites containing endogenously HA-tagged TgATAT (TgATATHA). The blot was probed with
antibodies recognizing the HA epitope or acetyl-K40–-tubulin. -Tubulin was also probed as a loading control. (B) IFAs of TgATATHA
parasites stained for HA (red, TgATATHA) or -tubulin (green) at the indicated stages of the parasite cell cycle. Images were merged with
the DNA stain DAPI (blue). (C) IFAs of RH parasites stained for acetyl-K40–-tubulin (red) or -tubulin (green) at the indicated stages of
the parasite cell cycle. Note that K40 acetylation is present on both spindle microtubules during mitosis and in the daughter subpellicular
microtubules throughout replication. Scale bar, 3 m.
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GFP-Cas9/sgRNA plasmid, we cotransfected a double-stranded DNA (dsDNA) oligomer
containing four stop codons ﬂanked by short regions of homology to the TgATAT Cas9
cleavage site to ensure disruption of the gene, and the loss of TgATATHA protein was
subsequently conﬁrmed by IFA (Fig. 5A). A control transfection was performed with the
aforementioned dsDNA oligomer and the GFP-Cas9 plasmid containing sequences
encoding an sgRNA targeting the unrelated and nonessential uracil phosphoribosyl-
transferase (UPRT) gene (53). Transfected parasites were inoculated onto human fore-
skin ﬁbroblasts (HFFs), and the infected monolayers were ﬁxed after 20 h so that the
expression of GFP-Cas9 could be observed by ﬂuorescence microscopy (Fig. 5B). In
parasites transfected with the UPRT-targeting construct, we observed 13% (30/231)
expressing GFP-Cas9; in contrast, GFP-Cas9 expression was observed at a lower fre-
quency in parasites transfected with TgATAT-targeting sgRNA (2.89%  0.93% [stan-
dard error of the mean], n  3). Importantly, -tubulin K40 acetylation was completely
abolished in the majority of the GFP-Cas9-positive parasites transfected with the
TgATAT-targeting sgRNA (57.8%  4.97%, n  3) but never diminished in GFP-Cas9-
FIG 5 Selective targeting of GFP-Cas9 to the TgATAT locus eliminates K40 acetylation. (A) Diagram showing the site on TgATAT targeted
by GFP-Cas9. The 20-bp TgATAT sgRNA sequence is shown; it is immediately upstream of the protospacer adjacent motif sequence (PAM,
red). The dsDNA oligomer used for recombination is shown, and in brackets are the numbers of bases of homology flanking the PAM
site. Underlined is the exogenous sequence introduced, including the four stop codons in bold. IFAs of dividing parasites expressing
GFP-Cas9 confirm that disruption of TgATAT and loss of K40 acetylation occur only when Cas9 is targeted to the TgATAT locus
(sgTgATAT). (B) IFA of TgATATHA parasites 40 h posttransfection with dsDNA oligomers and GFP-Cas9 targeted to either the UPRT
(sgUPRT) or the TgATAT (sgTgATAT) locus. Scale bar, 3 m. (C) Bar graph showing the percentage of GFP-Cas9-positive vacuoles that are
acetyl-K40 negative in parasites in which GFP-Cas9 was targeted to UPRT (sgUPRT) versus TgATAT (sgTgATAT) 20 or 40 h after
transfection. Error bars show the standard errors of the means (n  3).
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positive parasites transfected with the control UPRT-targeting sgRNA (Fig. 5B and C). At
40 h posttransfection, the number of GFP-Cas9-positive parasites lacking -tubulin K40
acetylation increased to 76.1%  2.01% (n  3) in TgATAT sgRNA-transfected popula-
tions. The inability to detect -tubulin K40 acetylation when the TgATAT locus is
selectively targeted for CRISPR/Cas9-mediated disruption strongly suggests that
TgATAT is the major -tubulin K40 acetyltransferase in Toxoplasma.
Loss of K40 acetylation causes microtubule defects and impairs replica-
tion. GFP-Cas9-expressing parasites transfected with the UPRT targeting control re-
tained acetylated -tubulin and displayed normal microtubule structures 40 h post-
transfection, as did TgATAT sgRNA transfectants that lacked GFP-Cas9 expression
(Fig. 6A). In contrast, TgATAT sgRNA transfectants expressing GFP-Cas9 that lost
-tubulin acetylation exhibited abnormal morphology (Fig. 6B, phase, compare acetyl-
K40-positive parasites in inset i with acetyl-K40-negative parasites in inset ii). 4=,6-
Diamidino-2-phenylindole (DAPI) staining revealed that the parasites lacking K40 acet-
ylation possessed nuclei that were grossly deformed, as if they failed to complete
karyokinesis (Fig. 6B, inset ii, asterisks). TgATAT sgRNA transfectants that retained
acetylated -tubulin contain nuclei that are uniform in shape and area (as measured in
pixels), whereas parasites lacking acetylated -tubulin possess a wide variety of DAPI-
staining structures that are abnormal in size and shape (Fig. 6B). Of note, while large
nuclei that appeared to have undergone genomic duplication were frequently ob-
served, the classic horseshoe shape of the nucleus routinely seen during cytokinesis
was largely absent from parasites lacking K40 acetylation. Further, many of the parasites
lacking K40 acetylation contained daughter parasites that were devoid of nuclear
material (Fig. 6C, inset i, arrowheads). Parasites lacking K40 acetylation were also
observed to possess numerous additional cytoplasmic -tubulin-containing structures,
many of which resembled caps of budding daughter cells (Fig. 6C, inset ii, arrows); in
these parasites, the mother’s microtubules and cytoskeleton fail to undergo recycling
to the residual body and instead appear to remain intact while the formation of
multiple daughter parasites seems to have been initiated. Despite this evidence of early
daughter bud initiation, proper formation of the mature cytoskeleton appears to be
impaired upon loss of K40 acetylation, as a variety of abnormal parasite sizes and
shapes are evident (Fig. 6C, phase and -tubulin channels). These phenotypes were not
observed in sgUPRT/GFP-Cas9-positive parasites, nor were they seen in the subset of
sgTgATAT/GFP-Cas9-positive parasites that retained tubulin acetylation, suggesting
that the defects in nuclear morphology and parasite division are due to loss of K40
acetylation and not to Cas9 expression. Together, these defects in cytokinesis and
cytoskeleton formation suggest that K40 acetylation likely impacts both spindle and
subpellicular microtubule populations.
To explore these replication defects more closely, we examined early steps in
Toxoplasma endodyogeny when the duplication of the centrosome and subsequent
division of the apicoplast occur (54). Control parasites containing K40 acetylation have
either a single or a duplicated centrosome per nucleus (Fig. 7A, arrowhead), as well as
a single apicoplast (Fig. 7B, arrowhead). Parasites lacking K40 acetylation can still
duplicate centrosomes; however, those with defects in nuclear division often had 2
centrosomes per nucleus (Fig. 7A, arrows). Additionally, parasites lacking K40-
acetylated -tubulin often contained large, irregular apicoplasts, suggesting a role for
acetylated -tubulin in the proper division of this organelle (Fig. 7B, arrows).
Centrosome duplication is followed by formation of the daughter bud apical
complex. As we observed evidence of apical conoid formation in the absence of K40
acetylation (Fig. 6C, arrowheads), we investigated whether K40 acetylation was re-
quired to recruit the IMC and IMC subcompartment proteins (ISPs) to the nascent
daughter cytoskeleton. During interphase, ISP1 localizes to the apical cap of each
parasite (Fig. 8A) and is recruited to the apical regions of the daughter buds during bud
formation (55). While parasites containing acetylated -tubulin showed two ISP1-
labeled apical caps per dividing parasite, loss of -tubulin acetylation resulted in
parasites containing multiple ISP1 structures per nucleus (Fig. 8A, arrowhead). In
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FIG 6 Defects in nuclear division and segregation in parasites lacking -tubulin K40 acetylation. (A)
TgATATHA parasites were transfected with GFP-Cas9-sgTgATAT and imaged at 40 h posttransfection.
Shown are transfectants lacking GFP-Cas9 expression, which display normal replication and have
microtubules containing K40 acetylation, as visualized with anti--tubulin (green) and acetyl-K40–
-tubulin (red) antibodies, with DAPI costain in blue. (B) Parasites expressing GFP-Cas9 lose K40
acetylation and contain abnormal nuclear morphology compared to that of parasites possessing K40
acetylation. Nuclei were visualized by DAPI staining (blue). Insets of acetyl-K40-positive (i) and
-negative (ii) parasites are shown and expanded in the lower panels. The DAPI-stained structures was
measured with ImageJ (n  100 nuclei). Double asterisks indicate a significant difference in mean
(Continued)
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parasites lacking acetylated -tubulin, IFAs staining for IMC3, which localizes to the IMC
following recruitment of ISP1 to daughter caps, revealed the presence of multiple IMC
structures forming within a single parasite (Fig. 8B, arrowheads). Taken together, these
results suggest that acetylation of -tubulin at K40 is dispensable for initiation of
mitosis and the early steps of daughter cell formation but is required for karyokinesis,
apicoplast division, and completion of Toxoplasma replication.
DISCUSSION
In this study, we addressed the biological role of -tubulin K40 acetylation in the
protozoan pathogen Toxoplasma by two independent genetic approaches that ablated
either the modifying enzyme or the substrate. Our mutational analyses of TgTUBA1
show that mutation of K40 to glutamine, an acetyl-lysine mimic, is tolerated, while
FIG 7 Centrosome duplication and apicoplast division in parasites lacking K40 acetylation. (A) Duplication of
the centrosomes occurs in the presence (top row, arrowhead) or absence of K40 -tubulin acetylation (bottom
row, arrowheads), as visualized by IFA staining for centrin 1 (red), acetyl-K40–-tubulin (green), and DNA
(DAPI, blue). K40-acetylated -tubulin and GFP-Cas9 (localized to the nucleus) were detected in the same
channel (green). Note the loss of acetylated -tubulin and GFP-Cas9-expressing parasites. Dotted lines encircle
individual parasites with arrowheads indicating multiple centrosomes. (B) IFAs of parasites stained for
apicoplast membrane protein Atrx1 (red), acetyl-K40–-tubulin (green), DNA (DAPI, blue), and GFP-Cas9
(green, nuclear). Apicoplasts that underwent normal division are visible in acetyl-K40-positive parasites (top
row, arrowhead). Apicoplasts that failed to divide in parasites lacking K40 acetylation (bottom row) are
indicated by arrows. Scale bars, 3 m.
Figure Legend Continued
area, as determined by unpaired t test with Welch’s correction for unequal variance (P  0.0085). (C)
Vacuoles containing parasites lacking acetylated microtubules (red) and showing aberrant pheno-
types detected by staining all of the microtubules (green) and DNA (blue) are shown. Inset i shows
that parasites lacking K40 acetylation have defects in microtubule structures and fail to partition
nuclear material into daughter parasites. Anucleate parasites are marked by arrowheads, while the
improperly segregated nuclear mass is indicated by the asterisk. Inset ii shows parasites containing
multiple -tubulin structures resembling daughter cell conoids (arrows). Scale bar, 3 m.
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mutation to arginine is inviable unless a secondary mutation that stabilizes microtu-
bules is made. Additionally, we have identiﬁed and characterized the KAT responsible
for mediating K40 acetylation, TgATAT, and have shown that loss of K40 acetylation
following CRISPR/Cas9-mediated disruption of the TgATAT locus severely impairs nu-
clear division and parasite replication.
Interestingly, many of the phenotypes we observed upon the disruption of K40
-tubulin acetylation parallel the effects observed when microtubules are destabilized
with oryzalin (13, 14, 39, 56, 57). Treatment of intracellular parasites with oryzalin
prevents completion of the daughter budding process, although nuclear size increased
and centriole replication occurred (41). Additional studies show that destabilization of
the spindle microtubules by oryzalin results in the formation of anuclear “zoids,” similar
to what we observed in parasites lacking K40 acetylation (Fig. 6C) (14). Importantly,
electron microscopic analysis of oryzalin-treated parasites showed that numerous
daughter conoids formed within mother parasites when nuclear division failed. This
bears a striking resemblance to the defects we observed in parasites lacking K40
acetylation, as we detect numerous structures resembling daughter caps that stain
positive for -tubulin, ISP1, and IMC3 (Fig. 6C and 8A and B). Early stages of parasite
division, including replication of genomic DNA, duplication of the centrosomes, and
daughter bud initiation, remain intact following loss of K40 acetylation, again mirroring
what is seen in oryzalin-treated parasites. In addition to defects in nuclear division, we
also saw evidence that apicoplast division is impaired in parasites without K40 acety-
lation (Fig. 7B, arrows). This agrees with studies showing that apicoplast division is a
FIG 8 Daughter cytoskeleton completion is impaired upon loss of K40 acetylation. (A) IFA visualizing ISP1
(red), acetyl-K40–-tubulin (green), DNA (DAPI, blue), and GFP-Cas9 (green, nuclear) in normal parasites (top)
versus those lacking acetylated -tubulin (bottom). Dotted lines encircle an individual parasites containing
excess daughter buds (bottom row, arrowhead), as visualized by numerous ISP1-positive apical cap structures.
(B) IFA stained for IMC3 (red), acetyl-K40–-tubulin (green), DNA (DAPI, blue), and GFP-Cas9 (green, nuclear).
Arrowheads indicate multiple IMC3-positive structures in parasites lacking K40 -tubulin acetylation, indicative
of partially formed daughter cells that failed to complete division. Scale bars, 3 m.
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microtubule-dependent process that occurs temporally with nuclear division and is
disrupted by oryzalin treatment (58). Together, these results suggest that acetylation of
-tubulin at K40 plays an important role in stabilizing both the subpellicular and mitotic
spindle populations of microtubules in Toxoplasma and that this microtubule stabili-
zation is especially critical for proper tachyzoite replication.
Our mutational analyses of TgTUBA1 showed that the function of K40 acetylation can
be mimicked by replacement of K40 with glutamine (Fig. 1), in agreement with ﬁndings
in both C. elegans and Rattus norvegicus (25, 59). Molecular dynamic simulations
provide a plausible explanation for the ability of the K40Q change to effectively mimic
K40 acetylation. In those simulations, acetylation of K40 on -tubulin disrupts an
intramonomeric salt bridge between -tubulin residues K40 and E55, a residue con-
served in Toxoplasma -tubulin. This disruption allows the acetyl group on K40 to form
a new salt bridge with H283 (also conserved in Toxoplasma) of an -tubulin monomer
in an adjacent protoﬁlament (30). Mutation of K40 to arginine would chemically allow
salt bridge formation with the carboxyl group of E55 while preventing interprotoﬁla-
ment salt bridge formation through H283. Conversely, mutation of K40 to glutamine
would constitutively promote salt bridge formation between the glutamine carboxyl
group (Q40) and the imidazole group (H283) located on the adjacent protoﬁlament.
Therefore, our ability to generate parasites expressing only Q40 in the nonstabilizing
V252L background suggests that salt bridge formation between protoﬁlaments is
important for microtubule structure and stability.
The ability to generate K40R mutants in the T239I background further speaks to the
role of K40 acetylation in Toxoplasmamicrotubule stability. T239I resides in the H7 helix
of -tubulin and is within the oryzalin binding pocket (60). Mutation of another binding
pocket residue (L136F) stabilized microtubules by promoting interactions between
-tubulin subunits within the microtubule lattice (41). Together, these data suggest
that oryzalin resistance generated by the mutation of binding pocket residues may also
lead to increased interprotoﬁlament interactions, which is similar to the proposed
mechanism by which K40 acetylation promotes microtubule stability discussed above.
Therefore, it is plausible that, like L136F, the T239I mutation stabilizes microtubules and
compensates for the loss of stability when K40 acetylation is nulliﬁed.
To further determine the biological importance of -tubulin K40 acetylation in
Toxoplasma, we identiﬁed and disrupted the -tubulin acetyltransferase gene TgATAT.
Endogenous tagging of the TgATAT locus revealed a cell cycle expression pattern that
correlated temporally with enriched regions of -tubulin acetylation during parasite
replication. These results agree with a recent report noting that -tubulin K40 acety-
lation occurs after spindle microtubule assembly in early daughter formation (37).
TgATAT is considerably larger than all previously characterized ATAT/Mec-17 proteins,
possessing highly divergent sequences ﬂanking the conserved Mec-17 domain
(Fig. 3A). Further bioinformatic analysis revealed that selected species within the
coccidian subclass of the Apicomplexa phylum also possess a large TgATAT homologue,
89 kDa in Neospora caninum (NCLIV_010560) and 98 kDa in Hammondia hammondia
(HHA_319600). Our CRISPR-mediated disruption of TgATAT indicates that it is the
primary -tubulin acetyltransferase in Toxoplasma.
While mammalian ATAT has been shown to localize to the lumen of the microtu-
bule, where it exerts its KAT activity (61), the considerably larger size of the apicom-
plexan orthologues may seem to preclude their access to this site. However, recent in
vitro studies using polymerized microtubules have shown that large macromolecules,
such as the full-length 6-11B-1 anti-acetyl-K40–-tubulin antibody (~150 kDa), are able
to enter the lumen of microtubules (61). Other studies have also reported that ATAT/
Mec-17 can bind to the exterior surface of microtubules; if microtubules undergo lateral
opening between protoﬁlaments, the K40 substrate could be exposed for acetylation
(62, 63). Further studies are required to address exactly how TgATAT gains access to its
substrate. Whether TgATAT has additional substrates is also an intriguing question for
future study. Besides ATAT/Mec-17 itself (64), no other substrates have been reported
for this family of KATs to date.
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Our analysis of K40 acetylation provides the ﬁrst detailed look at the functional role
and importance of tubulin modiﬁcations in Toxoplasma biology. Given that many other
tubulin PTMs have been reported for Toxoplasma (34), it is likely that these modiﬁca-
tions may also contribute to the regulation of microtubule function in the parasite.
While dissecting the biological role of these PTMs in other species is complicated by the
expression of multiple -tubulin isotypes, their function in Toxoplasma tachyzoites may
be easier to determine, as only TgTUBA1 is expressed in this stage. The identiﬁcation
and characterization of the enzymes responsible for mediating these PTMs provide an
exciting new ﬁeld of study for the development of novel therapeutics to treat toxo-
plasmosis.
MATERIALS AND METHODS
Antibodies. The following primary antibodies were used at the dilutions indicated: rabbit anti-T. gondii
-tubulin (1:2,000 [14]), mouse anti-acetyl-K40–-tubulin (1:2,000; Sigma 6-11-B-1), rabbit anti-acetyl-
K40–-tubulin (1:2,000; EMD Millipore ABT241), mouse anti-SAG1 (1:2,000; Genway), rat anti-IMC3
(1:2,000 [65]), rat anti-ISP1 (1:1,000 [55]), rabbit anti-centrin 1 (1:1,000 [66]), mouse anti-Atrx1 (1:2,000;
11G8 [67]), and rat anti-HA (1:1,000; Roche). The secondary antibodies used for immunoblot assays
included donkey anti-rabbit (1:2,000; GE Healthcare), sheep anti-mouse (1:5,000; GE Healthcare), and goat
anti-rat (1:2,000; GE Healthcare) antibodies conjugated to horseradish peroxidase. Fluorophore-
conjugated secondary antibodies (Alexa Fluor; Thermo Fisher) were used for IFAs at a 1:2,000 dilution
(1:1,000 for TgATATHA).
Parasite culture and transfection. Toxoplasma parasites were maintained in HFFs with Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C and 5%
CO2 (68). To assess parasite doubling time, puriﬁed tachyzoites were allowed to invade HFF monolayers
in 12-well plates for 2 h. Extracellular parasites were removed, and infected monolayers were incubated
for an additional 22 h before being ﬁxed in methanol for staining with a Differential Quik Stain kit
(Polysciences, Inc.). For generation of TgTUBA1 K40 mutants, wild-type RH parasites were electroporated
with 100 g of linearized plasmid and selection medium containing 2.5 M oryzalin was added 24 h
following transfection. Similarly, TgATATHA parasites were generated by transfection of RHΔhxΔKu80
parasites (50, 51) with 75 g of linearized plasmid and selected with medium containing 1 M
pyrimethamine. Following three passages under drug selection, resistant parasites were cloned by
limiting dilution in 96-well plates.
Generation of TgTUBA1 K40 mutant parasites. The plasmid construct described in reference 40
containing the TgTUBA1 genomic sequence carrying the T239I oryzalin resistance mutation was used as
the template for site-directed mutagenesis with the QuikChange II kit (Agilent) to introduce K40K silent,
K40R, and K40Q mutations with primers 1 to 6 (see Table S1 in the supplemental material). This construct
was then linearized by digestion with NotI-HF and HindIII-HF and transfected into RH strain parasites by
electroporation as described above. Transfected parasites were selected by growth in medium contain-
ing 2.5 M oryzalin, and surviving parasites were cloned by limiting dilution into 96-well plates. For the
generation of V252L mutant strains, T239I was restored to T239T, the V252L mutation was introduced
with the Q5 Site-Directed Mutagenesis kit (New England Biolabs) with primers 7 to 10, and stable clones
were selected as described above. Single clones were conﬁrmed by PCR ampliﬁcation of the TgTUBA1
locus from genomic DNA puriﬁed with the DNeasy Blood and Tissue kit (Qiagen) and sequencing with
primers 11 and 12.
Endogenous tagging of TgATAT. Genomic DNA was isolated from RHΔhxΔku80 parasites, and
primers 13 and 14 (see Table S1 in the supplemental material) were used to amplify ~1.2 kb of the
TgATAT gene just upstream of the stop codon. The in-Fusion HD cloning kit (Clontech) was used to clone
the ampliﬁed TgATAT sequence into the PacI restriction site of pLIC.HA3.DHFR (69). Prior to transfection,
75 g of plasmid DNA was linearized by NcoI and electroporated into RHΔhxΔku80 parasites. Following
three passages under selection with 1.0 M pyrimethamine, parasites were cloned by limiting dilution
and positive clones were identiﬁed by immunoblotting.
Immunoblotting. Freshly egressed parasites were passed through 3.0-m ﬁlters to remove host cell
debris and then washed in phosphate-buffered saline (PBS). Parasites were lysed in radioimmunopre-
cipitation assay buffer supplemented with complete protease inhibitor cocktail (Roche), sonicated twice
for 10 s each time with a microtip sonicator, and centrifuged to remove insoluble debris. Cleared lysate
was subjected to SDS-PAGE with precast 4 to 20% Mini-PROTEAN TGX gels (Bio-Rad), and resolved
proteins were transferred to nitrocellulose membranes with the Transblot SD semidry transfer system
(Bio-Rad). Membranes were blocked in 5% milk–Tris-buffered saline–Tween 20 (TBST) and probed with
primary antibodies for 1.5 h at room temperature or overnight at 4°C. Membranes were washed three
times for 10 min each time in TBST and probed with secondary antibodies for 45 min at room
temperature. Membranes were washed again three times for 10 min each time in TBST, and proteins
were detected with SuperSignal West Femto substrate (Thermo Fisher) and imaged on a FluorChem R
imager (Bio-Techne).
IFAs. Conﬂuent HFF monolayers grown on coverslips in 24-well plates were infected with freshly
lysed parasites. For all images of microtubules, cells were ﬁxed with cold methanol, washed with PBS, and
blocked for 30 min with 3% BSA in PBS. For imaging of TgATATHA, cells were ﬁxed with 4% paraformal-
dehyde in PBS, blocked for 30 min in 3% BSA–PBS, and permeabilized with PBS with 0.2% Triton X-100
(PBS-T) for 10 min. Primary antibodies diluted in 3% BSA–PBS were applied for 1.5 h at room temperature
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or (for TgATATHA) overnight at 4°C in BSA–PBS-T. Coverslips were washed three times for 15 min each
time with PBS, and secondary antibodies were added in 3% BSA–PBS for 45 min. Following three 15-min
washes in PBS, coverslips were mounted with Vectashield antifade mounting medium (Vector Labs)
containing DAPI to visualize nuclei.
CRISPR-mediated disruption of TgATAT. The plasmid described in reference 53 (GFP-Cas9/sgUPRT)
was used for site-directed mutagenesis with the Q5 kit to delete the HA epitope tag with primers 15 and
16 and to mutate the sgRNA sequence to target the TgATAT locus with primers 17 and 18. TgATATHA
parasites were transfected with 50 g of the puriﬁed TgATAT- or UPRT-targeted GFP-Cas9 plasmid and
50 g of 90-bp dsDNA oligonucleotides 19 and 20. Transfected populations were used to inoculate
coverslips and were ﬁxed at the time points indicated in the ﬁgures.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://dx.doi.org/10.1128/
mSphere.00088-15.
TABLE S1, DOCX ﬁle, 0.01 MB.
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